Admedus Ltd well | 合法醫療器材資訊網
2020年4月23日—Admeduswell-placedforgrowthfollowingtransformationalquarter.Thefirst-in-humansurgicalaorticvalvereplacement(SAVR)trialisunderway, ...
Admedus Ltd[1] (ASX:AHZ[2]) has recorded cash receipts of $1.7 million during a transformational March 2020 quarter with a cash balance plus short-term investments of $11 million.
In line with its transformation to a structural heart company, Admedus delivered a major milestone by beginning the first-in-human SAVR trial of its 3D single-piece aortic valve.
First patient implantOn March 27, the first patient was successfully implanted.
Professor Bart Meuris MD, PhD, chief of cardiovascular surgery at the University Hospitals, Leuven, Belgium, performed the surgery and the patient recovered swiftly enough to be discharged within one week.
Valve function was as expected, showing improved blood flow, replicating the results observed in the earlier animal study.
Fifteen patients will be enrolled in the trial and observed for six mon...
Admedus ( | 合法醫療器材資訊網
Admedus Changes Name to Anteris Technologies Ltd | 合法醫療器材資訊網
Admedus Changes Name to Anteris Technologies Ltd | 合法醫療器材資訊網
Admedus Changes Name to Anteris Technologies Ltd ... | 合法醫療器材資訊網
Admedus changes name to Anteris Technologies to reflect ... | 合法醫療器材資訊網
Admedus Ltd well | 合法醫療器材資訊網
Admedus Ltd | 公司資料| ASX | 合法醫療器材資訊網
Anteris Technologies Limited | 合法醫療器材資訊網
ASX: AHZ | 合法醫療器材資訊網
Investors Centre | 合法醫療器材資訊網
【“樂脈”遠端灌流導管】許可證字號:衛署醫器輸字第018797號
器材品名:“樂脈”遠端灌流導管許可證字號:衛署醫器輸字第018797號註銷狀態:註銷日期:註銷理由:有效日期:2023/04/15發證日期:2...
【“阿瑪迪斯”卡地歇補片】許可證字號:衛部醫器輸字第031863號
器材品名:“阿瑪迪斯”卡地歇補片許可證字號:衛部醫器輸字第031863號註銷狀態:註銷日期:註銷理由:有效日期:2023/12/11發證日期...
【“樂脈”普特主動脈阻斷導管】許可證字號:衛署醫器輸字第019882號
器材品名:“樂脈”普特主動脈阻斷導管許可證字號:衛署醫器輸字第019882號註銷狀態:註銷日期:註銷理由:有效日期:2024/06/01發證...
【“樂脈”普特灌沖血管閉塞導管】許可證字號:衛署醫器輸字第018226號
器材品名:“樂脈”普特灌沖血管閉塞導管許可證字號:衛署醫器輸字第018226號註銷狀態:註銷日期:註銷理由:有效日期:2022/08/28發...
【“樂脈”普特血管閉塞導管】許可證字號:衛署醫器輸字第019307號
器材品名:“樂脈”普特血管閉塞導管許可證字號:衛署醫器輸字第019307號註銷狀態:註銷日期:註銷理由:有效日期:2023/10/28發證日...